The safety of breast-conserving surgery in patients who achieve a complete pathologic response after neoadjuvant chemotherapy (Q79969459)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16862596%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

title

The safety of breast-conserving surgery in patients who achieve a complete pathologic response after neoadjuvant chemotherapy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16862596%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

1 reference

7

Kelly K Hunt

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16862596%20AND%20SRC:MED&resulttype=core&format=json

Ana Maria Gonzalez-Angulo

27 December 2019

3

object named as

Ana M Gonzalez-Angulo

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16862596%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

4

Judy C Boughey

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16862596%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

8

S Eva Singletary

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16862596%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

9

Gildy V Babiera

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16862596%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

5

Aman U Buzdar

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16862596%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

author name string

Florentia Peintinger

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16862596%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

W Fraser Symmans

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16862596%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

T Kuan Yu

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16862596%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Anthony Lucci

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16862596%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Funda Meric-Bernstam

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16862596%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Henry M Kuerer

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16862596%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

publication date

1 September 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16862596%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16862596%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

volume

107

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16862596%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16862596%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

page(s)

1248-1254

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16862596%20AND%20SRC:MED&resulttype=core&format=json

The effect on tumor response of adding sequential preoperative docetaxel to preoperative doxorubicin and cyclophosphamide: preliminary results from National Surgical Adjuvant Breast and Bowel Project Protocol B-27.

27 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22111

7 January 2021

Preoperative chemotherapy in primary operable breast cancer: results from the European Organization for Research and Treatment of Cancer trial 10902.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22111

7 January 2021

Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-18

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22111

7 January 2021

Primary chemotherapy in operable breast cancer: eight-year experience at the Milan Cancer Institute

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22111

7 January 2021

Surgical conservation planning after neoadjuvant chemotherapy for stage II and operable stage III breast carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22111

7 January 2021

Effect of preoperative chemotherapy on the outcome of women with operable breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22111

7 January 2021

Clinical course of breast cancer patients with complete pathologic primary tumor and axillary lymph node response to doxorubicin-based neoadjuvant chemotherapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22111

7 January 2021

Prognostic significance of a complete pathological response after induction chemotherapy in operable breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22111

7 January 2021

Significantly higher pathologic complete remission rate after neoadjuvant therapy with trastuzumab, paclitaxel, and epirubicin chemotherapy: results of a randomized trial in human epidermal growth factor receptor 2-positive operable breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22111

7 January 2021

Neoadjuvant chemotherapy for operable breast carcinoma larger than 3 cm: a unicentre randomized trial with a 124-month median follow-up. Institut Bergonié Bordeaux Groupe Sein (IBBGS)

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22111

7 January 2021

Long-term outcome of neoadjuvant therapy for locally advanced breast carcinoma: effective clinical downstaging allows breast preservation and predicts outstanding local control and survival

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22111

7 January 2021

Preoperative chemotherapy in patients with operable breast cancer: nine-year results from National Surgical Adjuvant Breast and Bowel Project B-18

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22111

7 January 2021

Revision of the American Joint Committee on Cancer staging system for breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22111

7 January 2021

Prospective evaluation of paclitaxel versus combination chemotherapy with fluorouracil, doxorubicin, and cyclophosphamide as neoadjuvant therapy in patients with operable breast cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22111

7 January 2021

Factors predictive of distant metastases in patients with breast cancer who have a pathologic complete response after neoadjuvant chemotherapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22111

7 January 2021

Primary chemotherapy in the treatment of breast cancer: the University of Texas M. D. Anderson Cancer Center experience.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22111

7 January 2021

Three dimensional staging of breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22111

7 January 2021

Potential applicability of balloon catheter-based accelerated partial breast irradiation after conservative surgery for breast carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22111

7 January 2021

Breast conservation after neoadjuvant chemotherapy: the MD Anderson cancer center experience

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22111

7 January 2021

A prospective trial of preoperative chemotherapy in resectable breast cancer: predictors of breast-conservation therapy feasibility

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22111

7 January 2021

Accuracy of physical examination, ultrasonography, and mammography in predicting residual pathologic tumor size in patients treated with neoadjuvant chemotherapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22111

7 January 2021

Is surgery necessary after complete clinical remission following neoadjuvant chemotherapy for early breast cancer?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22111

7 January 2021

Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22111

7 January 2021

Identifiers

DOI

10.1002/CNCR.22111

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16862596%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

1 reference